2025 annual financial data
Century Therapeutics 2025 Operating margin
Direct answer
Operating margin was -13.78%.
Operating income was -15,040,000 USD and net income was -9,580,000 USD.
Operating cash flow was -103,876,000 USD.
Get free Century Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 109,164,000 USD
- Operating income
- -15,040,000 USD
- Net income
- -9,580,000 USD
- Operating cash flow
- -103,876,000 USD